R&D How automation can drive a competitive advantage for CROs & ... For CROs and CDMOs, automation is key to ensuring long-term success.
R&D Agentic AI and the human element: Building trustworthy autom... The future of clinical trials isn’t about replacing people. It’s about empowering them with smarter tools.
R&D Simplicity wins: How Lean principles and smart automation ca... Manufacturers truly outperforming their peers share a defining trait: a ruthless commitment to simplicity, based on Lean principles and automation.
Digital Beyond regulation: 4 AI trends transforming life sciences te... Artificial intelligence (AI) is becoming embedded into the fabric of quality, compliance, and production systems.
Digital 2026: When clinical intelligence moves from promise to pract... We are about to enter a new era of clinical intelligence. The era of "digital" as a separate activity in healthcare will begin to dissolve in 2026.
Sales & Marketing The hidden IP problem holding innovators back For organisations active in the US market, the impact of patent marking is financial, not administrative.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
